<DOC>
	<DOC>NCT01033643</DOC>
	<brief_summary>This study will evaluate if MK3614, given in multiple rising doses, is safe and tolerated in male subjects with mild to moderate hypertension.</brief_summary>
	<brief_title>A Multiple Dose Study of MK3614 (3614-002)</brief_title>
	<detailed_description />
	<criteria>hypertensive male subjects an otherwise healthy subject with grade 1 or 2 arterial hypertension being treated with a single antihypertensive drug subject is a nonsmoker and has not used nicotine or nicotine products for at least 6 months subject is in generally good health subject has a history of clinically significant abnormalities or diseases subject has a history of stroke, chronic seizures, or major neurological disorder subject has a functional disability that can interfere with rising from a sitting position to the standing position subject has any personal or family history of a bleeding or a clotting disorder subject has a history of frequent nose bleeds or has recurrent or active gingivitis subject has a history of cancer subject has a history of clinically significant cardiac disease subject is unable to refrain from or anticipates the use of any medication, including prescription and nonprescription drugs or herbal remedies approximately 2 weeks prior to the administration of study drug subject consumes excessive amounts of alcohol subject consumes excessive amounts of caffeinated beverages per day subject has had major surgery, donated or lost 1 unit of blood or participated in another investigational study within 4 weeks of study subject has a history of significant multiple and/or severe allergies (including latex) to prescription or nonprescription drugs or food subject is currently a regular user of any illicit drugs or has a history of drug abuse within approximately 1 year</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>